Literature DB >> 25912478

P53-dependent miRNAs mediate nitric oxide-induced apoptosis in colonic carcinogenesis.

Weiwei Li1, Wenxiao Han1, Yiming Ma1, Liang Cui2, Yantao Tian2, Zhixiang Zhou2, Hongying Wang3.   

Abstract

Both miRNAs and nitric oxide (NO) play important roles in colonic inflammation and tumorigenesis. Resistance of colonic epithelial cells to apoptosis may contribute to tumor development. We hypothesized that some miRNAs could increase the resistance of colonic cancer cells to nitric oxide-induced apoptotic cell death. Here we show that NO induced apoptosis and stimulated expression of some miRNAs. Loss of p53 not only blocked NO-induced apoptosis but also dramatically inhibited the expression of NO-related miRNAs, such as miR-34, miR-203, and miR-1301. In addition, blockage of p53-dependent miRNAs significantly reduced NO-induced apoptosis. Furthermore, forced expression of these miRNAs rendered HT-29 cells, which are resistant to apoptosis with mutant p53, more sensitive to NO-induced apoptotic cell death. Most interestingly, in a colitis-associated colon cancer mouse model, the level of miRNAs dropped significantly, accompanied by downregulation of p21, which is a key target gene of p53. In human colorectal cancer samples, the expression of miR-34 significantly correlated with the level of inducible nitric oxide synthase (iNOS). We contend that increased NO production may select cells with low levels of p53-dependent miRNAs which contributes to human colonic carcinogenesis and tumor progression.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Colon cancer; Inflammation; Nitric oxide; miRNA; p53

Mesh:

Substances:

Year:  2015        PMID: 25912478     DOI: 10.1016/j.freeradbiomed.2015.04.016

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

1.  The apoptotic inducible effects of salicylic acid on hepatoma cell line: relationship with nitric oxide signaling.

Authors:  Yahui Liu; Yong Wang; Yue Hu; Shuxiong Ge; Keshi Li; Shuangshuang Wang; Li Li
Journal:  J Cell Commun Signal       Date:  2017-02-09       Impact factor: 5.782

2.  Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.

Authors:  Yan Zhou; Rui-hua Zhao; Kuo-fu Tseng; Kun-peng Li; Zhi-gang Lu; Yuan Liu; Kun Han; Zhi-hua Gan; Shu-chen Lin; Hai-yan Hu; Da-liu Min
Journal:  Acta Pharmacol Sin       Date:  2016-02-29       Impact factor: 6.150

3.  MicroRNA-1301 inhibits proliferation of human glioma cells by directly targeting N-Ras.

Authors:  Tongle Zhi; Kuan Jiang; Chuanzhuo Zhang; Xiupeng Xu; Weining Wu; Er Nie; Tianfu Yu; Xu Zhou; Zhongyuan Bao; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

4.  Influence of nitric oxide signaling mechanisms in cancer.

Authors:  R Ramírez-Patiño; G Avalos-Navarro; L E Figuera; J J Varela-Hernández; L A Bautista-Herrera; J F Muñoz-Valle; M P Gallegos-Arreola
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

Review 5.  Nitric Oxide: The Forgotten Child of Tumor Metabolism.

Authors:  Bahar Salimian Rizi; Abhinav Achreja; Deepak Nagrath
Journal:  Trends Cancer       Date:  2017-08-18

6.  O2-3-Aminopropyl diazeniumdiolates suppress the progression of highly metastatic triple-negative breast cancer by inhibition of microvesicle formation via nitric oxide-based epigenetic regulation.

Authors:  Fenghua Kang; Jiayi Zhu; Jianbing Wu; Tian Lv; Hua Xiang; Jide Tian; Yihua Zhang; Zhangjian Huang
Journal:  Chem Sci       Date:  2018-08-03       Impact factor: 9.825

Review 7.  Aberrant Expression of miR-1301 in Human Cancer.

Authors:  Chenming Zhong; Yiyao Dong; Qiudan Zhang; Chunhui Yuan; Shiwei Duan
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

8.  Aberrant expression of five miRNAs in papillary thyroid carcinomas.

Authors:  De-Hui Qiao; Xue-Mei He; Xian Deng; Yi-Chi Ji; Hui Yang; Lian Cheng; Xiang-Yu Zhou
Journal:  J Clin Lab Anal       Date:  2021-07-16       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.